AMG:ETR
Amgen Inc
€358.85
arrow_downward
-0.07%(-0.25) 1D
Okt 5, 4:09:42 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa AMG...
Buksan
€359.50
Mataas
€360.35
Mababa
€356.40
Mkt. cap
216.02B
Avg. na dami
473.00
Dami
838.00
Mataas nang 52-wk
€383.05
Mababa nang 52-wk
€247.65
Bilang ng mga empleyado
32K
Buksan
€359.50
Mataas
€360.35
Mababa
€356.40
Mkt. cap
216.02B
Avg. na dami
473.00
Dami
838.00
Mataas nang 52-wk
€383.05
Mababa nang 52-wk
€247.65
Bilang ng mga empleyado
32K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Investing.com
·
1 oras ang nakalipas
Cantor Fitzgerald reiterates Amgen stock Neutral rating at $400
AD HOC NEWS
·
7 oras ang nakalipas
Scotiabank raises target for Amgen stock from USD 450.00 to USD 500.00
AD HOC NEWS
·
22 oras ang nakalipas
Amgen announces Sjögren's results as Amgen stock trades flat at EUR 358.63
The Motley Fool
·
23 oras ang nakalipas
Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Tungkol sa Amgen Inc
CEORobert A. Bradway
Mga Empleyado31.5K
Itinatag1980
HeadquartersThousand Oaks, California, Estados Unidos
Sektor-
Websiteamgen.com